Article Details
Retrieved on: 2018-11-16 07:52:36
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Finally, <b>Sofinnova Ventures</b> Inc acquired a new position in Entasis Therapeutics in the third quarter worth approximately $12,840,000. Hedge funds ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here